Explore Dr. Agarwal’s Health Care IPO details, including IPO dates, financial statements, valuation, peer comparison and more.
Dr. Agarwal’s Health Care Limited offers a wide range of treatments, including cataract and refractive surgeries, consultations, diagnostics, non-surgical treatments, and the sale of optical products and eye care pharmaceuticals. With a market share of approximately 25% in India’s organized eye care service chain segment as of FY 2024, Dr. Agarwal’s operates the largest network of eye care service facilities in the country. As of September 30, 2024, the company operated 209 facilities across India, categorized into Primary, Secondary, and Tertiary Facilities under a scalable hub-and-spoke model. This structure allows for deep market penetration and resource efficiency, enhancing accessibility and patient outcomes. The company also has an international presence with 16 facilities across nine countries in Africa. Backed by strong institutional investors such as Temasek Holdings and TPG.
Key Points:
Discover essential information crucial for understanding an IPO, including the Price Band, Fresh Issue, Offer For Sale, Total IPO Size and more. Explore these key details to gain insight into the company's public offering.
Fields | Details |
---|---|
IPO Dates | 29 Jan - 31 Jan 2025 |
IPO Price Band | ₹382 - ₹402 per share |
Fresh Issue | ₹300 crore |
Offer For Sale | 67,842,284 shares (₹2,727.26 crore) |
Total IPO Size | ₹3,027.26 crore |
Face Value | ₹1 |
Listing On | BSE, NSE |
Explore important dates like IPO opening, closing, listing and others, outlining the journey of the Public Offering. This will help you grasp the entire IPO journey effortlessly.
Event | Date |
---|---|
IPO Opening Date | 29 Jan 2025 |
IPO Closing Date | 31 Jan 2025 |
Basis Of Allotment | 03 Feb 2025 |
Refunds | 04 Feb 2025 |
Demat Transfer | 04 Feb 2025 |
IPO Listing Date | 05 Feb 2025 |
Explore a comprehensive financial data table showcasing key metrics including revenue, expenses, net income, and others. Gain valuable insights about the company's financial performance at a glance, facilitating informed decision-making and strategic planning for subscribing to the IPO.
Period Ended | 31st March 2022 | 31st March 2023 | 31st March 2024 | Sep 2024 |
---|---|---|---|---|
Total Income | 713.78 | 1,031.49 | 1,376.45 | 837.94 |
Total Expenses | 657.02 | 947.90 | 1,235.88 | 777.59 |
Net Profit/Loss | 43.16 | 103.23 | 95.05 | 39.56 |
NPM (*) | 6.05 | 10.01 | 6.91 | 4.72 |
Total Assets | 1,026.13 | 1,825.17 | 2,752.82 | 3,393.41 |
Total Liabilities | 792.31 | 1,166.10 | 1,373.31 | 1,835.28 |
* NPM represents the net profit margin, calculated as a percentage. All other figures are presented in crore (₹cr)
Uncover significant valuation metrics such as EPS (Earnings Per Share), ROE (Return on Equity), ROCE (Return on Capital Employed), D/E Ratio (Debt-to-Equity Ratio), Current Ratio, and EBITDA Margin. These key indicators offer insights into the company's financial standing and performance, aiding in informed investment decisions.
Period Ended | 31st March 2022 | 31st March 2023 | 31st March 2024 | Sep 2024 |
---|---|---|---|---|
EPS | 1.83 | 4.00 | 3.13 | 1.00 |
ROE (%) | 19.96 | 23.12 | 9.33 | 2.69 |
ROCE (%) | 15.02 | 15.18 | 14.61 | 8.30 |
D/E Ratio | 2.71 | 1.30 | 0.70 | 0.66 |
Current Ratio | 1.10 | 1.03 | 1.90 | 1.62 |
EBITDA MARGIN (%) | 27.99 | 27.52 | 29.54 | 27.27 |
* Compiled from DRHP/RHP for valuation purposes.
Compare key financial metrics with industry peers to gain valuable insights into the company's performance compared to its competitors.
Name | Revenue | P/E | EPS | RoNW | NAV |
---|---|---|---|---|---|
Dr. Agarwal's Health Care Limited | 1,332.15 | 128.43 | 3.13 | 6.21 | 50.53 |
Apollo Hospitals Enterprise Limited | 19,059.20 | 107.11 | 62.50 | 12.97 | 481.93 |
Max Healthcare Institute Limited | 6,849.00 | 95.88 | 10.84 | 12.58 | 86.54 |
Fortis Healthcare Limited | 6,892.92 | 82.11 | 7.93 | 7.82 | 101.48 |
Global Health Limited | 3,275.11 | 57.49 | 17.80 | 16.46 | 108.17 |
Narayana Hrudayalaya Limited | 5,018.25 | 33.14 | 38.86 | 27.37 | 141.98 |
Krishna Institute of Medical Sciences Limited | 2,498.14 | 79.79 | 7.75 | 16.96 | 228.47 |
Aster DM Healthcare Limited | 3,698.90 | 136.07 | 3.60 | 3.63 | 71.62 |
Rainbow Children's Medicare Limited | 1,296.90 | 67.90 | 21.38 | 17.24 | 124.03 |
* Revenue in (₹cr), RoNW in (%), EPS, NAV in (₹). P/E ratio is based on the highest price from the IPO price band.
Investor Type | Shares Offered |
---|---|
Qualified Institutional Buyer (QIB) | Not more than 50% |
Non-Institutional Investor (NII/HNI) | Not less than 15% |
Retail Individual Investor (RII) | Not less than 35% |
Investor Type | Subscribed |
---|---|
Qualified Institutional Buyer (QIB) | 1.01 |
Non-Institutional Investor (NII/HNI) | 0.12 |
Retail Individual Investor (RII) | 0.24 |
Total | 0.42 |
* All figures represent multiples of the subscription. Check subscriptions for other ongoing issues here.
KFin Technologies Limited
Phone: +91 40 6716 2222/ 18003094001
Email: einward.ris@kfintech.com
Website: www.kfintech.com
Dr. Agarwal’s Health Care Limited
1 st Floor, Buhari Towers, No.4, Moores Road, Off Greams Road, Near Asan Memorial School, Chennai 600 006, Tamil Nadu, India
Phone: +91 44 4378 7777
Email: www.dragarwals.co.in
Website: www.dragarwals.co.in